Snider D P, Segal D M
Experimental Immunology Branch, National Cancer Institute, Bethesda, MD 20892.
J Immunol. 1989 Jul 1;143(1):59-65.
Bispecific heteroconjugate antibodies can bind soluble protein Ag to APC and thereby enhance Ag presentation. We used such antibodies to bind hen egg lysozyme (HEL) to various structures on the surface of normal splenic B cells to determine which structures would provide the best targets for enhanced presentation. We found that HEL was presented efficiently to hybridoma T cells if bound to sIgD, sIgM, or class I or II MHC molecules, but not at all if bound to Fc gamma RII, or B220 molecules on B cells. The efficiency of presentation of HEL was measured as a function of the amount of 125I-HEL bound per cell. HEL was presented with 5 to 10 times greater efficiency when bound to sIg, than when bound to MHC molecules. When compared on the basis of the amount of HEL bound, sIgD and sIgM functioned equally as target structures, as did class I and class II MHC molecules. Large amounts of HEL bound to B220, but no presentation resulted, indicating that focusing HEL to the APC surface was not sufficient for presentation to occur. HEL was internalized rapidly and in large amounts when bound to sIgD or sIgM, but slowly and in small amounts, when bound to class I or class II MHC molecules. Thus, a rapid rate of internalization may in part explain the high efficiency of Ag presentation after binding to sIg. However, the small amount of HEL internalized via MHC molecules was utilized efficiently for presentation. These results indicate that sIgM and sIgD serve equally on normal B cells to focus and internalize Ag and enhance Ag presentation, but that class I or class II MHC molecules can also be used to internalize Ag and enhance Ag presentation, perhaps by a separate intracellular processing pathway.
双特异性异源共轭抗体可将可溶性蛋白抗原结合至抗原呈递细胞(APC),从而增强抗原呈递。我们使用此类抗体将鸡卵溶菌酶(HEL)结合至正常脾B细胞表面的各种结构,以确定哪些结构可为增强呈递提供最佳靶点。我们发现,如果HEL与sIgD、sIgM或I类或II类MHC分子结合,它能有效地呈递给杂交瘤T细胞,但如果与B细胞上的FcγRII或B220分子结合,则根本不会被呈递。HEL的呈递效率通过每个细胞结合的125I-HEL量来衡量。与MHC分子结合相比,HEL与sIg结合时的呈递效率要高5至10倍。基于结合的HEL量进行比较时,sIgD和sIgM作为靶结构的功能相同,I类和II类MHC分子也是如此。大量HEL与B220结合,但未导致呈递,这表明将HEL集中于APC表面不足以发生呈递。当与sIgD或sIgM结合时,HEL迅速且大量地被内化,但与I类或II类MHC分子结合时,内化缓慢且量少。因此,内化速率快可能部分解释了与sIg结合后抗原呈递的高效率。然而,通过MHC分子内化的少量HEL被有效地用于呈递。这些结果表明,在正常B细胞上,sIgM和sIgD在聚焦和内化抗原以及增强抗原呈递方面发挥相同作用,但I类或II类MHC分子也可用于内化抗原并增强抗原呈递,可能是通过一条独立的细胞内加工途径。